chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Pt had no history of varicella and varicella titer was negative. Fifteen days post vax pt started running a fever. 10/29/01 pt noted the appearance of red spots that over 10 days erupted and evolved like varicella only with a longer time period than expected. On 10/31/01 pt was given Atarax for itching and rash. Pt continued with a low grade fever of 100.3-100.5 daily. On 11/7/01, a nurse made a home visit which was followed by blood tests and a chest x-ray on 11/8/01, and pt was started on Acyclovir. On 11/10/01, pt had more blood tests and a urinalysis. She was started on Cipro for a possible UTI. On 11/13/01, pt's fever increased to 102F, and she was admitted to the hospital for evaluation.
Pt rec'd 11/13/02, DTaP, right arm IM - 5cc upper, IPV right thigh IM 5cc - lower, 2nd MMR left thigh SQ on 11/14/02. Pt was seen for left thigh swollen red warm to touch X AM (11/14/2002). MMR reaction vs cellulitis.
Patient had swelling and redness at site of injection, however chief complaint was itching...mostly on stomach..kind of all over she said.
Gastrointestinal issues, nausea, bowel movement problems, indigestion, and abdominal pain.
pt recv vax; breaking out in hives on 5may95,that would last about 20 mins & then go away; this pattern cont thru the eve of 6may;to er & then pt was given dph; hives still persist 10may95;
Initial report received from healthcare professional, who is also patient on 14 September 2012. A 36-year-old male patient had received intradermal (ID) FLUZONE intradermal in left deltoid (lot number UT4466BA and anatomical site of administration were not reported) on 08 September 2012. The patient had Gluten allergy and intolerance. The patient had no ongoing illness. On 09 September 2012 i.e. one day post vaccination, the patient had induration and erythema measuring 2 x 3 inches. The patient's outcome was unknown. List of documents held by the sender: None.
Hives all over non-ejection are appear 7 hours post second dose accompanied with swollen lips. Benadryl medication taken approximately 30 minutes after on-site seemed to subdue symptoms.
This spontaneous report was received from a licensed practitioner nurse referring to a 3 month-old child of unknown gender. There was no pertinent medical history, concomitant medication or drug allergies/drug reaction described. The reporter stated that on 16-JUL-2015, the chills was administered an improperly stored dose of LIQUID PEDVAXHIB injection (lot # K026533, with expiration date: 07-AUG-2017; dose, frequency and route were not reported). No adverse effects were reported. It was unknown if the patient sought medical attention. Product quality complaint (PQC) was not involved. This is one of several reports received from the same source. Additional information has been requested.
Information has been received from medical records received on 10-AUG-2015 regarding an experience reported in a case in litigation (MARRS # 1403USA000676.) A female patient of unknown age was vaccinated with PNEUMOVAX23 (date not reported.) The patient reported that "PNEUMOVAX does not take on any gamma globulin." No further information was reported. All available medical records will be provided upon request. Additional information is not expected.
Initial report received on 24/Feb/2006 from a study site participating in the above mentioned trial in the USA under the reference number MTA30. A 32 year old male subject received an injection of Menactra, manufacturer, lot number not reported, on 11/Jan/2006. On that day, he experienced dizziness, shortness of breath, myalgia, chills, fever and headache. One day later, he was examined in an emergency room and complained of continuous headache, body aches, tightness around his chest, mild photophobia, dizziness and warmth, mild swelling and tenderness at the injection site. He also complained of a "sore throat swelling sensation." He denied shortness of breath during examination, and his pulse ox on room air was 96-97%. His temperature was 101.5 degrees Fahrenheit. He denied focal weakness or numbness. He had no history of previous upper respiratory infection symptoms, cough or runny nose. The subject has a history of vasovagal syncope, rectal bleeding and an allergy to penicillin. He was treated with Tylenol per os and intravenous fluids. Per the emergency record, a creatinine was ordered. However, additional laboratory test, an EKG or chest x-ray were not ordered. He was subsequently discharged from the emergency room with the diagnosis of a "vaccine reaction." The subject had no dizziness or pain at the time of discharge. Recovery status of additional events was not reported. Per the investigator, this is a non-serious adverse event that was related to the study vaccine.
Throat became itchy, and pt. was having a hard time breathing.  Pt's face began to swell.  Pt. was given a breathing treatment, a shot of Benadryl, as well as a shot of an Epi-pen jr.
My mother had a stroke on 28Jan2021 sometime after 9:30 AM the morning after getting the first dose of the Pfizer Covid vaccine; Cerebral infarction; This is a spontaneous report from a contactable consumer (reporting for mother). A 94-year-old female patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number and expiry date unknown as not available or provided to reporter at the time of report completion) via an unspecified route of administration on 27Jan2021 in right arm at single dose for COVID-19 immunization. Medical history included coronary artery disease and hypertension. There were no concomitant medications. The patient was not pregnant. No other vaccine was received in four weeks. The patient did not have covid prior vaccination and not have covid tested post vaccination. The patient had a stroke on 28Jan2021 sometime after 9:30 AM the morning after getting the first dose of the Pfizer Covid vaccine and was hospitalized due to stroke for 6 days from Jan2021. The patient then experienced cerebral infarction in 2021 and died due to it on 04Feb2021. Treatment received for events stroke and cerebral infarction included tPA injection. The outcome of events stroke and cerebral infarction was fatal. An autopsy was not performed.  Information on the lot/batch number has been requested.; Reported Cause(s) of Death: Cerebral infarction
She started to get constant, left-sided chest pain focally near her sternum 1 day after receiving the vaccine.  She had a 3 to 4/10 rating for her pain with exacerbations that would wake her up at night.  Her pain did get so bad that she pursued evaluation for her chest pain at the emergency department on 05/21/2021.    Could not find any cardiac etiology for her chest pain but asked her to follow-up with primary care.  She saw me in clinic today, 6/15/2021, where I performed a history and physical assessment, including a breast exam.  Findings were that she had bilateral mastodynia but had focal pain worse in the left chest where she has had pain all along.
pt recv vax; sore leg x 2 days p/ shots; rash & fever p/ 6 days lasting 1-2 days p/ vax; 4-5 mins of shaking & crying w/in first 1-2 days p/ vax;
Administration of lyophilized portion of Menveo using a different diluent; Administration of lyophilized portion of Menveo using a different diluent; This case was reported by a other health professional via sales rep and described the occurrence of wrong solution used in drug reconstitution in a patient who received Men ACWY-CRM NVS (Menveo) for prophylaxis.   On an unknown date, the patient received Menveo. On an unknown date, unknown after receiving Menveo, the patient experienced wrong solution used in drug reconstitution and inappropriate dose of vaccine administered. On an unknown date, the outcome of the wrong solution used in drug reconstitution and inappropriate dose of vaccine administered were unknown.   Additional Information: GSK Receipt Date: 10-JUN-2022 Reporter's Comment: The reporter reported that, the patient was administered with lyophilized portion of Menveo using a different diluent. Additional Supportive Information: The patient was administered with lyophilized portion of Menveo using a different diluent, which led to wrong solution used in drug reconstitution and inappropriate dose of vaccine administered. The case had been linked to US2022AMR091748,reported by the same reporter, for a different patient.; Sender's Comments:  US-GLAXOSMITHKLINE-US2022AMR091748:Same reporter
Itching and rash on left arm. Itching on left hand down to injection site. Patient states injection site has rash, is on lower biceps about a grapefruit in size, patient sent to urgent care.
Less than 10 spots on body a couple on face for 3 days, low grade temp.
Patient scheduled for 2nd dose of moderna vaccine. Patient was administered a Pfizer vaccine instead of the 2nd dose of Moderna. No adverse reactions, full triage completed. No abnormalities.
Became extremely ill on Thu 10/24/19 (two days after I received the 3 vaccines). Symptoms included feeling extremely feverish and fatigued, an extremely dry throat and an unproductive cough which which felt like a sore throat mixed in with layrngitis (losing about 95% of my speaking voice), and persistent discomfort and pressure in my eyes. I was not comfortably able to speak for a week and did not retain my speaking voice for 3 weeks.  I remember feeling like these were not mild or typical flu symptoms for me because of the severity of losing my voice, how long it took to fully get my voice back, the dry non-productive cough (vs. a burning sore throat feeling that would normally result from coughing so much), and the general malaise of all the symptoms that I felt for up to 3 weeks. I took 3 days off of work because of how ill I felt and because I could not talk (Thu 10/24, Fri 10/25, and Mon 10/28). Even after coming back to work on 10/29, I felt I probably should have taken at least 2-3 more days off.   Saw my primary care physician on Tue 10/29/19 to discuss my symptoms and obtain a work absence excuse note for having missed previous days (per my employer). No treatment was administered or medications prescribed. His notes indicate: "discussed typical resolution, warning symptoms reviewed"   Saw the same primary care physician again on Mon 11/11/19 for a physical. I mentioned that in hindsight, I thought these vaccines may have contributed to my falling ill but was told in a very short and muffled response, "I don't think so". There was no further conversation in regards to this because his response swayed me based on his position of expertise but also how uncomfortable I felt. However, he did not document this specific inquiry on my appointment notes. I felt later on after my 3 weeks of feeling ill that these vaccines most likely made me ill and that I should have pushed the conversation. The obvious connection between the vaccines and becoming ill two days later is a glaring concern for me. The Comprehensive Metabolic Panel and Lipid Panel blood test results I did that day came back ok with no concerns and no need for follow up.
Information has been received from a physician concerning a male, who was vaccinated with varicella virus vaccine, live (Oka/Merck). Subsequently the patient developed breakthrough chickenpox. It is unknown if medical attention was sought. No other information was provided at the time of this report. There was no product complaint. No further information is available.
slightly elevated fever; nausea; vomiting; joint pain; muscle pain; This is a spontaneous report received from a Pfizer Sponsored Program received from a contactable female consumer (patient)   A female patient of unspecified age received second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection) on an unspecified date at single dose via an unspecified route of administration for COVID-19 immunization.  The patient received first dose of BNT162B2 on an unspecified date, at single dose via an unspecified route of administration for COVID-19 immunization. Relevant medical history and concomitant medications were not reported. It was reported that 45 days since 2nd dose she still presented slightly elevated fever, nausea, vomiting, muscle and joint pain. At the time of the reporting the patient had not yet recovered from the events.   Information on the lot/batch number has been requested.
Moderate to severe 'irritability" following immunizations at 2 and 9 month old visits. Described by mother as "hyperactivitiy".
He has had not treatment except to discuss with the pharmacist. He was thinking it would get better, but he, in fact, believes it to be worse. I as his wife know that it is at least no better. He has an ENT MD and that is who we will contact when he seeks treatment.
12 days after she received her Varicella and MMR she got a mild, non raised rash all over her body. Then, approximately 12 days after that rash, she had 3 boils that formed on her leg, trunk and face. All three boils eventually opened up and are now in the healing process. She is still recovering.
This spontaneous report as received from a pharmacy technician refers to a 3 patients of unknown ages whose on an unspecified dates was vaccinated with an expired dose of PNEUMOVAX23 during the time period of 14-SEP-2012 thought 18-SEP-2012. The PNEUMOVAX23 had an expiration date of 14-AUG-2012. No symptoms were reported. Additional information has been requested. Follow up information was provided during a phone call on 26-SEP-2012 stating the health care professional could not supply patient names, date of birth, dates of vaccination or dates of events. Follow up was received on 26-SEP-2012 reported that the 39 year old female patient received an expired dose of PNEUMOVAX23 (lot # 669382/1490Z) on 13-SEP-2012. The source case 1209USA008402 was split into three cases. This case is also linked to case 1210USA000521.
Got Covid on 12/3/2022. Confirmed with home test, called Dr., got Paxlovid Rx. Took that for 5 days, felt better.  New symptoms of bad head cold on 12/13/2022. Did home covid test, was positive. Called Dr., said to quarantine for another 5 days, then mask for 5.
I developed a "cold" on 11/1, tested positive for COVID on 11/3.
pt recv vax 12DEC97 & 14DEC97 pt was seen @ ER w/T105;CBC, blood cult & UA showed all nl results & were negative for cult & sensitivity;
Soreness began immediately after shot. Pt began having redness and swelling in the evening of 11/16/13, after 6 pm. Pt rtc on 11/17/13 due to redness and warmth.  Tx with Bactrim DS with good effect.  11/19/13, redess almost gone, but area itches now.  Pt treated in clinic for cellulitis.
PATIENT REPORTED SIGNIFICANT SWELLING AT AND AROUND INJECTION SITE ABOUT 2 HOURS AFTER RECEIVING VACCINATION.  AREA WAS RAISED AND ITCHY. NOTHING WAS USED FOR TREATMENT .
24 hours after received Menactra vaccine developed aggressive behavior, numbness and tingling in both upper and lower extremities. He through his phone, was yelling and crying. Episode lasted about 15-20 minutes. Does not remember events of aggressive behavior. Numbness and tingling of lower extremity resolved but upper extremity persisted 48 hours after injection. Seen by neurology and told positive adverse RXN to Menactra. Scheduled for EEG. No rashes noted. no swelling noted, Positive mild meningitis due to vaccine per neurology. Being followed by neurology.
a girl received Pediarix expired dose; This non-serious case was reported by a nurse via call center representative and described the occurrence of expired vaccine used in a 4-year-old female patient who received DTPa-HBV-IPV (Pediarix) (batch number Z4R9R, expiry date 14-MAY-2023) for prophylaxis.   On 16-MAY-2023, the patient received the 1st dose of Pediarix. On 16-MAY-2023, an unknown time after receiving Pediarix, the patient experienced expired vaccine used (Verbatim: a girl received Pediarix expired dose). The outcome of the expired vaccine used was unknown.   This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences.   Additional Information: GSK Receipt Date: 16-May-2023  Nurse reported that on 16th May 2023 morning, a girl received Pediarix expired dose. This Pediarix vaccines was administer as a catch up only dose, and it was a third Dtap, IPV and hep-B dose on the series. The reporter consented to follow up by email.
After 7 days, patient noticed that it spread and now she has slightly red area that is 4inchlong and 3inch wide; developed itching on upper right arm; oval shaped circle that was red on injection site; stiffness; This spontaneous case was reported by a consumer and describes the occurrence of MUSCULOSKELETAL STIFFNESS (stiffness), ERYTHEMA (After 7 days, patient noticed that it spread and now she has slightly red area that is 4inchlong and 3inch wide), VACCINATION SITE PRURITUS (developed itching on upper right arm) and VACCINATION SITE ERYTHEMA (oval shaped circle that was red on injection site) in a 76-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 022M20A and 007M20A) for COVID-19 vaccination.     No Medical History was provided by the reporter.  Concomitant products included AMOXICILLIN TRIHYDRATE, BROMHEXINE HYDROCHLORIDE (BROMOLIN), CALCIUM CITRATE, CETIRIZINE HYDROCHLORIDE (ZYRTEC [CETIRIZINE HYDROCHLORIDE]), DOXAZOSIN, BISACODYL (DULCOLAX [BISACODYL]), FLUTICASONE PROPIONATE (FLOVENT), FLUOROURACIL, FLUTICASONE PROPIONATE (FLONASE [FLUTICASONE PROPIONATE]), LEUCOVORIN CALCIUM, LISINOPRIL, LORAZEPAM, MULTIVITAMINS [VITAMINS NOS], FISH OIL (OMEGA 3 [FISH OIL]), OXALIPLATIN, POLICOSANOL, DABIGATRAN ETEXILATE MESILATE (PRADAXA), PROCHLORPERAZINE MALEATE (COMPAZINE [PROCHLORPERAZINE MALEATE]), TIOTROPIUM BROMIDE MONOHYDRATE (SPIRIVA), CURCUMIN, VITAMIN C [ASCORBIC ACID] and VITAMIN D3 for an unknown indication.   On 28-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) .5 milliliter. On 24-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to .5 milliliter. On 24-Feb-2021,  after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced MUSCULOSKELETAL STIFFNESS (stiffness). On 28-Feb-2021, the patient experienced VACCINATION SITE PRURITUS (developed itching on upper right arm) and VACCINATION SITE ERYTHEMA (oval shaped circle that was red on injection site). On an unknown date, the patient experienced ERYTHEMA (After 7 days, patient noticed that it spread and now she has slightly red area that is 4inchlong and 3inch wide). The patient was treated with CORTISONE at an unspecified dose and frequency and DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL [DIPHENHYDRAMINE HYDROCHLORIDE]) at an unspecified dose and frequency. At the time of the report, MUSCULOSKELETAL STIFFNESS (stiffness), ERYTHEMA (After 7 days, patient noticed that it spread and now she has slightly red area that is 4inchlong and 3inch wide), VACCINATION SITE PRURITUS (developed itching on upper right arm) and VACCINATION SITE ERYTHEMA (oval shaped circle that was red on injection site) outcome was unknown.            Action taken with mRNA-1273 in response to the event was not applicable.  Treatment information also included ice application.   This case was linked to MOD-2021-035521 (Patient Link).
Soreness in left arm region three weeks after second dose; painful/stiff when lifting arm up past shoulder; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 42 year-old female patient (not pregnant) received bnt162b2 (BNT162B2), administered in arm left, administration date 11May2021 09:00 (Lot number: EW0164) at the age of 42 years as dose 2, single for covid-19 immunisation. Relevant medical history included: "phantom burning smell" (unspecified if ongoing), notes: Not chronic but after recovering from COVID19 back in January 2021, I periodically smell phantom burning smell. It smells like as if someone lit a match and blew it out but there no one else around smells it.; "if covid prior vaccination: Yes" (unspecified if ongoing), notes: Not chronic but after recovering from COVID 19 back in January 2021, I periodically smell phantom burning smell. There were no concomitant medications. Vaccination history included: Bnt162b2 (lot number=EW0164,, administration time=09:00 AM,, dose number=1,, vaccine location=Left arm), administration date: 19Apr2021, when the patient was 42 years old, for COVID-19 immunization. The following information was reported: PAIN IN EXTREMITY (non-serious) with onset 31May2021 15:00, outcome "not recovered", described as "Soreness in left arm region three weeks after second dose"; MUSCULOSKELETAL STIFFNESS (non-serious) with onset 31May2021 15:00, outcome "not recovered", described as "painful/stiff when lifting arm up past shoulder". Therapeutic measures were not taken as a result of pain in extremity, musculoskeletal stiffness.  Additional Information: known allergies were none. The patient has Covid prior vaccination. Facility where the most recent COVID-19 vaccine was administered: Other. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient did not receive any other medications within 2 weeks of vaccination. Clinical course was reported as, patient had Soreness in left arm region three weeks after second dose. Onset of side effects are outside expected range and started 31May2021. Could be lymph nodes but not certain. As of right now, soreness is bearable but has increased. It is more pain-ful/stiff when lifting arm up past shoulder. AE treatment was reported as, Birth Control. The patient has not tested for COVID-19 since the vaccination. Device Date was reported as, 01Jun2021.  Follow-up attempts are completed. No further information is expected.
For 3 years in a row I have had the flu exactly 2 months after the vaccine. I have taken the regular flu shots for years and never had a problem. Only with the high-dose shots (3) have I had a problem.
rigors; This is a spontaneous report from a contactable physician. A male patient of an unspecified age started received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; lot number and expiry date: unknown), via an unspecified route of administration on an unspecified date at a single dose for COVID-19 immunization. The patient's medical history and concomitant medications were not reported.  The patient experienced rigors on an unspecified date. Patients presented within 12-24 hours and persisted for 12-24 hours. The AE subsided after 48 hours.  No follow-up attempts are possible. Information about batch/Lot number cannot be obtained.
On 12/25/2021 I tested positive for COVID with a rapid home test. Two weeks later I went to see my doctor, he recommended to take some supplements like zinc and told me to continue Vitamin D. I started to feel better probably within a week after my doctor visit, but I still had symptoms of fatigue, diarrhea, night sweats and fever. I still have ongoing symptoms that come and go, I even had symptoms yesterday. The most bothersome symptom I have is an irregular heartbeat. I have an upcoming appt with my cardiologist next month. I have a follow up appointment with my PCP in May.